Moderna's COVID-19 Vaccine Candidate Gets More Good News

The biotech company Moderna released new data Monday morning that strengthens the case for its COVID-19 vaccine. It concludes the vaccine is 94% effective — and strongly protects against serious illness. Based on these latest findings, the company plans to submit an application for emergency use authorization to the Food and Drug Administration today.

They build on Moderna's previously reported findings, based on a smaller number of cases detected in its study of about 30,000 volunteers.

Overall, the study identified 185 cases in the people who received a placebo shot, compared with 11 cases in people who got the active vaccine. These latest findings are similar to results from Pfizer, which has developed a similar vaccine. And, like the Pfizer vaccine, this one seems to prevent severe cases.

https://www.npr.org/sections/health-shots/2020/11/30/940037920/more-good-news-for-modernas-covid-19-vaccine-candidate?utm_source=npr_newsletter&utm_medium=email&utm_content=20201130&utm_term=4993323&utm_campaign=breaking-news&utm_id=48780983&orgid=309